Bovine Lactoferrin for treatment of anaemia associated with advanced cancer

Not Applicable

• Conditions: Anaemia; Cancer Cachexia; Blood - Anaemia; Cancer - Lung - Non small cell; Musculoskeletal - Other muscular and skeletal disorders

• Registration Number: ACTRN12617000913370
• Lead Sponsor: ational Cancer Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-06-22
• Last Update Posted: 12 November 2018

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 130

Inclusion Criteria

Patients with cachexia related to underlying stage IV non-small cell lung cancer,
Apparent healthy controls should not being diagnosed with any type of cancer or have been treated from cancer.

Exclusion Criteria

Metastasis in the brain or in bone, patients with severe illness, unstable angina, congestive heart failure, heart attack during the last month, cognitive impairment, unable to give a consent.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
We will measure haemoglobin concentration by using blood samples on two occasions, 1st before starting the study as baseline and 2nd sample will be taken after 12 weeks (end of the study). [12 weeks]

Secondary Outcome Measures

Name	Time	Method
Change in serum level of iron[after 12 weeks];Change in red blood cells (RBCs) count[12 weeks];measure human lactoferrin from serum using Lactoferrin Human Simple Step ELISA Kit[12 weeks from start of the second phase, which is the end of second phase.<br><br>]